An Open Label Study of Adefovir Dipivoxil for the Treatment of Patients With Chronic Hepatitis B Related Advanced Fibrosis or Cirrhosis.
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2012
At a glance
- Drugs Adefovir dipivoxil (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 10 Jun 2017 Biomarkers information updated
- 16 May 2010 Actual patient number added as 155 as reported by ClinicalTrials.gov.
- 16 May 2010 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.